Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN ...

Detailed price information for Aptose Biosciences Inc (APTOF) from The Globe and Mail including charting and trades.

Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...

What Is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a type of blood cancer that starts in your bone marrow, which is the soft inner part of your bones where all your blood cells are made.

The goal of acute myeloid lymphoma (AML) treatment is to put you into remission -- when you have no leukemia cells found in your blood or bone marrow and you have no symptoms of the disease. Most ...

The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...